0001829126-26-001292.txt : 20260213 0001829126-26-001292.hdr.sgml : 20260213 20260212180107 ACCESSION NUMBER: 0001829126-26-001292 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260213 DATE AS OF CHANGE: 20260212 EFFECTIVENESS DATE: 20260213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KALA BIO, Inc. CENTRAL INDEX KEY: 0001479419 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 270604595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-573473 FILM NUMBER: 26627984 BUSINESS ADDRESS: STREET 1: 1167 MASSACHUSETTS AVENUE CITY: ARLINGTON STATE: MA ZIP: 02476 BUSINESS PHONE: 781-996-5252 MAIL ADDRESS: STREET 1: 1167 MASSACHUSETTS AVENUE CITY: ARLINGTON STATE: MA ZIP: 02476 FORMER COMPANY: FORMER CONFORMED NAME: Kala Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20091223 D 1 primary_doc.xml X0708 D LIVE 0001479419 KALA BIO, Inc. 1167 MASSACHUSETTS AVENUE ARLINGTON MA MASSACHUSETTS 02476 781-996-5252 DELAWARE None Kala Pharmaceuticals, Inc. Corporation true AVI MINKOWITZ 1167 MASSACHUSETTS AVENUE ARLINGTON MA MASSACHUSETTS 02476 Executive Officer Director Chief Executive Officer, Chief Financial Officer and Director DAVID LAZAR 1167 MASSACHUSETTS AVENUE ARLINGTON MA MASSACHUSETTS 02476 Director Director HILLEL POSEN 1167 MASSACHUSETTS AVENUE ARLINGTON MA MASSACHUSETTS 02476 Director Director CHAIM BERGER 1167 MASSACHUSETTS AVENUE ARLINGTON MA MASSACHUSETTS 02476 Director Director YONATAN COLMAN 1167 MASSACHUSETTS AVENUE ARLINGTON MA MASSACHUSETTS 02476 Director Director BRENDAN PURDY 1167 MASSACHUSETTS AVENUE ARLINGTON MA MASSACHUSETTS 02476 Director Director Biotechnology Decline to Disclose 06b false 2026-01-30 false true false 44905 FM Global Markets Inc. 000174843 None None 130 ADELAIDE STREET WEST SUITE 3002 TORONTO Z4 CANADA (FEDERAL LEVEL) M5H 3P5 CO COLORADO DE DELAWARE FL FLORIDA NY NEW YORK WY WYOMING true 4200000 2250600 1949400 The issuer issued 1,125,300 shares of Series AAA Preferred Stock at $2.00 per share for aggregate proceeds of $2,250,600 in a private placement pursuant to Rule 506(b) of Reg. D and 974,700 shares pursuant to Rule 903 of Reg. S. false 20 38988 0 0 false KALA BIO, Inc. /s/ Avi Minkowitz Avi Minkowitz CEO, CFO and Director 2026-02-12